SRSF3 and cancer: For instance, the RBM4a‐SRSF3‐MAP4K4 axis in adipogenesis and cancer demonstrates how splicing regulators generate exon‐specific isoforms that differentially activate JNK/MAPK pathways, contributing to pro‐apoptotic or migratory effects [31, 33].